- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-oligomer
- Ligands
- 2 x FLC: CITRATE ANION(Non-covalent)
- 24 x ETX: 2-ETHOXYETHANOL(Non-covalent)
ETX.2: 9 residues within 4Å:- Chain A: Y.52, F.53, Q.54, N.55, Y.91, R.92
- Chain D: S.41, L.44, E.45
Ligand excluded by PLIPETX.3: 2 residues within 4Å:- Chain A: R.27, K.28
Ligand excluded by PLIPETX.4: 2 residues within 4Å:- Chain A: H.31, D.35
Ligand excluded by PLIPETX.5: 7 residues within 4Å:- Chain A: G.37, S.38, G.41, G.42, G.45, K.46, T.49
Ligand excluded by PLIPETX.6: 5 residues within 4Å:- Chain A: N.15, F.70, P.71, Y.99, T.103
Ligand excluded by PLIPETX.7: 5 residues within 4Å:- Chain B: S.9, Q.10, S.11, R.98
- Ligands: ETX.8
Ligand excluded by PLIPETX.8: 5 residues within 4Å:- Chain B: S.11, K.15, K.96, R.98
- Ligands: ETX.7
Ligand excluded by PLIPETX.9: 4 residues within 4Å:- Chain B: I.86, H.87
- Chain D: N.16
- Ligands: ETX.22
Ligand excluded by PLIPETX.10: 4 residues within 4Å:- Chain B: L.25, K.33, R.37
- Ligands: ETX.12
Ligand excluded by PLIPETX.11: 3 residues within 4Å:- Chain B: E.56, E.59, K.63
Ligand excluded by PLIPETX.12: 8 residues within 4Å:- Chain B: H.21, A.24, L.25, R.37, A.40
- Chain C: G.50, G.51
- Ligands: ETX.10
Ligand excluded by PLIPETX.13: 6 residues within 4Å:- Chain B: D.29, V.31, V.32
- Chain D: Y.27, K.28, D.29
Ligand excluded by PLIPETX.15: 9 residues within 4Å:- Chain B: S.41, L.44, E.45
- Chain C: Y.52, F.53, Q.54, N.55, Y.91, R.92
Ligand excluded by PLIPETX.16: 2 residues within 4Å:- Chain C: R.27, K.28
Ligand excluded by PLIPETX.17: 2 residues within 4Å:- Chain C: H.31, D.35
Ligand excluded by PLIPETX.18: 7 residues within 4Å:- Chain C: G.37, S.38, G.41, G.42, G.45, K.46, T.49
Ligand excluded by PLIPETX.19: 5 residues within 4Å:- Chain C: N.15, F.70, P.71, Y.99, T.103
Ligand excluded by PLIPETX.20: 5 residues within 4Å:- Chain D: S.9, Q.10, S.11, R.98
- Ligands: ETX.21
Ligand excluded by PLIPETX.21: 5 residues within 4Å:- Chain D: S.11, K.15, K.96, R.98
- Ligands: ETX.20
Ligand excluded by PLIPETX.22: 4 residues within 4Å:- Chain B: N.16
- Chain D: I.86, H.87
- Ligands: ETX.9
Ligand excluded by PLIPETX.23: 4 residues within 4Å:- Chain D: L.25, K.33, R.37
- Ligands: ETX.25
Ligand excluded by PLIPETX.24: 3 residues within 4Å:- Chain D: E.56, E.59, K.63
Ligand excluded by PLIPETX.25: 8 residues within 4Å:- Chain A: G.50, G.51
- Chain D: H.21, A.24, L.25, R.37, A.40
- Ligands: ETX.23
Ligand excluded by PLIPETX.26: 6 residues within 4Å:- Chain B: Y.27, K.28, D.29
- Chain D: D.29, V.31, V.32
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Benz, J. et al., Structural Insights into the Effector - Immunity System Tae4/Tai4 from Salmonella typhimurium. Plos One (2013)
- Release Date
- 2013-05-22
- Peptides
- Putative cytoplasmic protein: AC
Putative periplasmic protein: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AB
BD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-oligomer
- Ligands
- 2 x FLC: CITRATE ANION(Non-covalent)
- 24 x ETX: 2-ETHOXYETHANOL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Benz, J. et al., Structural Insights into the Effector - Immunity System Tae4/Tai4 from Salmonella typhimurium. Plos One (2013)
- Release Date
- 2013-05-22
- Peptides
- Putative cytoplasmic protein: AC
Putative periplasmic protein: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AB
BD
B